Sapuła Mariusz, Krankowska Dagny, Wiercińska-Drapało Alicja
Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Hospital for Infectious Diseases, Warsaw, Poland.
Interdiscip Perspect Infect Dis. 2020 May 7;2020:1307232. doi: 10.1155/2020/1307232. eCollection 2020.
Erysipelas and cellulitis are common, acute, bacterial infections of the skin and subcutaneous tissue. The incidence of these infections is growing, and the recurrence rate is high. Effective antibiotic prophylaxis is available, but insufficient data exist on the risks factors for recurrent infection.
To compare comorbidities and laboratory findings in patients with single-episode and recurrent erysipelas/cellulitis in order to identify risk factors for recurrent erysipelas/cellulitis.
A cross-sectional study, which included patients hospitalized in the Department of Infectious and Tropical Diseases and Hepatology of the Medical University of Warsaw due to erysipelas and cellulitis during 3 consecutive years (July 2016-June 2019).
The study included 163 patients, of which 98 had a first episode of erysipelas/cellulitis and 65 had a recurrence. The recurrent infection was significantly associated with a history of lymphedema (12.3% in the recurrent group vs. 2.0% in the first-episode group, =0.015), a higher BMI (35.4 vs. 31.2, respectively, =0.002), chronic obstructive pulmonary disease (10.8% vs. 2.0%, =0.030), and a shorter history of symptoms prior to hospitalization (6.0 days vs. 11.8 days, =0.004). Patients with the first episode of infection were more likely to have had minor local trauma directly preceding the symptoms of infection (20.4% in the first-episode group vs. 1.5% in the recurrent group, =0.001).
Patients with lymphedema and obesity should be viewed at high risk of developing recurrence of erysipelas and thus should be considered as candidates for antibiotic prophylaxis and other prevention methods. Minor local trauma directly preceding the skin infection does not by itself confer a higher risk for erysipelas recurrence. More research is needed to assess the association of recurrent skin and soft-tissue infection to preceding minor local trauma, individual components of the metabolic syndrome, and COPD.
丹毒和蜂窝织炎是皮肤和皮下组织常见的急性细菌感染。这些感染的发病率正在上升,且复发率很高。虽然有有效的抗生素预防措施,但关于复发性感染的危险因素的数据不足。
比较单次发作和复发性丹毒/蜂窝织炎患者的合并症和实验室检查结果,以确定复发性丹毒/蜂窝织炎的危险因素。
一项横断面研究,纳入了连续3年(2016年7月至2019年6月)因丹毒和蜂窝织炎在华沙医科大学传染病、热带病和肝病科住院的患者。
该研究纳入了163例患者,其中98例为丹毒/蜂窝织炎首次发作,65例为复发。复发性感染与淋巴水肿病史显著相关(复发组为12.3%,首次发作组为2.0%,P=0.015)、较高的体重指数(分别为35.4和31.2,P=0.002)、慢性阻塞性肺疾病(10.8%对2.0%,P=0.030)以及住院前症状持续时间较短(6.0天对11.8天,P=0.004)。首次发作感染的患者在感染症状出现前更有可能有轻微的局部创伤(首次发作组为20.4%,复发组为1.5%,P=0.001)。
淋巴水肿和肥胖患者发生丹毒复发的风险较高,因此应被视为抗生素预防和其他预防方法的候选对象。皮肤感染前直接出现的轻微局部创伤本身并不会增加丹毒复发的风险。需要更多的研究来评估复发性皮肤和软组织感染与先前轻微局部创伤、代谢综合征的各个组成部分以及慢性阻塞性肺疾病之间的关联。